[
    [
        {
            "time": "",
            "original_text": "埃克替尼销量首超百万盒，贝达净利润却锐减三成！为什么？下一个10亿品种是它？",
            "features": {
                "keywords": [
                    "埃克替尼",
                    "销量",
                    "百万盒",
                    "贝达",
                    "净利润",
                    "锐减",
                    "三成"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "埃克替尼销量首超百万盒，贝达净利润却锐减三成！为什么？下一个10亿品种是它？",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【天风医药】贝达药业：埃克替尼销量高增长，新品种步入收获期有望迎来业绩拐点",
            "features": {
                "keywords": [
                    "天风医药",
                    "贝达药业",
                    "埃克替尼",
                    "销量",
                    "高增长",
                    "新品种",
                    "收获期",
                    "业绩拐点"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【天风医药】贝达药业：埃克替尼销量高增长，新品种步入收获期有望迎来业绩拐点",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]